2022

following participants of the WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products; Other participants; Representatives of the Developing Countries Vaccine Manufacturers Network; Representatives of the Emerging Biopharmaceutical Manufacturers Network; Representatives of the IFPMA; Representatives of IGBA; Representative of the Latin American Association of Pharmaceutical Industries; Representative of the Singapore Association of Pharmaceutical Industries; WHO Secretariat; Wadhwa, Meenu; Kang, H. N.; Thorpe, Robin; Knezevic, I.; Aprea, P.; Bielsky, M. C.; Ekman, N.; Heim, H. K.; Joung, J.; Kurki, P.; Lacana, E.